Clinical trial
Infusion Laboratory: Protocol 4 (Dihydrexidine) - 13
NCT00000348 · National Institute on Drug Abuse (NIDA), NIH · Unknown status
Key facts
| NCT number | NCT00000348 |
|---|---|
| Title | Infusion Laboratory: Protocol 4 (Dihydrexidine) - 13 |
| Official title | Infusion Laboratory: Protocol 4 (Dihydrexidine) |
| Lead sponsor | National Institute on Drug Abuse (NIDA), NIH |
| Status | Unknown status |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Cocaine-Related Disorders |
| Intervention type | Drug |
| Interventions | Dihydrexidine |
| Enrollment | 0 |
| First posted | Sep 21, 1999 |
| Last update posted | Jan 11, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: